PDF Version Printer-Friendly Version
Vital Signs
DMS research funding rose 13% last year to $127 million in FY04
Research funding awarded to Dartmouth Medical School increased 13% in the last fiscal year—from $112.4 million in 2002-03 to $126.8 million in 2003-04, according to the DMS Fiscal Office. The previous year's increase had been a modest 1%, so the return to a double-digit rise was welcome news. Since 2001, the Medical School's income from research grants and contracts has grown 58%.
The fact that more and more research is interdisciplinary, and thus interdepartmental, makes it harder to associate grants with specific departments. But based on the primary departmental af- filiation of the principal investigator, two departments doubled their research funding in the past year—Genetics, from $3 million
to $7 million, and Physiology, from $7 million to $14 million—while other departments showed steady increases. The largest dollar totals went, as in recent years, to Medicine ($21 million), Psychiatry ($20 million), and Community and Family Medicine ($19 million).
Sources: The U.S. Department of Health and Human Services, which includes the National Institutes of Health, accounted for 68% of the research funding awarded to DMS in 2003-04. Other sources included private and governmental foundations and institutes; corporations; and the state of New Hampshire.
—Jennifer Durgin
If you'd like to offer feedback about this article, we'd welcome getting your comments at DartMed@Dartmouth.edu.
This article may not be reproduced or reposted without permission. To inquire about permission, contact DartMed@Dartmouth.edu.